BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $808,350 | +149594.4% | 7,500 | +31.6% | 0.00% | +50.0% |
Q1 2024 | $540 | -13.9% | 5,700 | -16.2% | 0.00% | -33.3% |
Q4 2023 | $627 | +258.3% | 6,800 | +94.3% | 0.00% | +200.0% |
Q3 2023 | $175 | -43.4% | 3,500 | -28.6% | 0.00% | 0.0% |
Q2 2023 | $309 | +5.1% | 4,900 | -25.8% | 0.00% | – |
Q1 2023 | $294 | +254.2% | 6,600 | +247.4% | 0.00% | – |
Q4 2022 | $83 | -100.0% | 1,900 | -67.8% | 0.00% | -100.0% |
Q3 2022 | $388,000 | +92.1% | 5,900 | +47.5% | 0.00% | +100.0% |
Q2 2022 | $202,000 | -54.1% | 4,000 | -42.0% | 0.00% | -50.0% |
Q1 2022 | $440,000 | -40.5% | 6,900 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $739,000 | -5.4% | 6,900 | -9.2% | 0.00% | 0.0% |
Q3 2021 | $781,000 | +5.8% | 7,600 | -9.5% | 0.00% | 0.0% |
Q2 2021 | $738,000 | 0.0% | 8,400 | +10.5% | 0.00% | 0.0% |
Q1 2021 | $738,000 | -55.5% | 7,600 | -48.6% | 0.00% | -50.0% |
Q4 2020 | $1,659,000 | +148.7% | 14,800 | +105.6% | 0.01% | +100.0% |
Q3 2020 | $667,000 | +4.4% | 7,200 | -12.2% | 0.00% | 0.0% |
Q2 2020 | $639,000 | +43.9% | 8,200 | +7.9% | 0.00% | +50.0% |
Q1 2020 | $444,000 | -0.9% | 7,600 | +35.7% | 0.00% | 0.0% |
Q4 2019 | $448,000 | -58.7% | 5,600 | -62.2% | 0.00% | 0.0% |
Q3 2019 | $1,086,000 | +55.6% | 14,800 | +100.0% | 0.00% | -33.3% |
Q2 2019 | $698,000 | +89.7% | 7,400 | +60.9% | 0.00% | +50.0% |
Q1 2019 | $368,000 | +120.4% | 4,600 | +48.4% | 0.00% | +100.0% |
Q4 2018 | $167,000 | -37.0% | 3,100 | -8.8% | 0.00% | 0.0% |
Q3 2018 | $265,000 | -35.7% | 3,400 | -47.7% | 0.00% | -50.0% |
Q2 2018 | $412,000 | -23.8% | 6,500 | +10.2% | 0.00% | 0.0% |
Q1 2018 | $541,000 | +84.0% | 5,900 | +51.3% | 0.00% | +100.0% |
Q4 2017 | $294,000 | +83.8% | 3,900 | +69.6% | 0.00% | 0.0% |
Q3 2017 | $160,000 | -86.2% | 2,300 | -90.0% | 0.00% | -80.0% |
Q2 2017 | $1,160,000 | +43.0% | 22,900 | +12.8% | 0.01% | +25.0% |
Q1 2017 | $811,000 | +4.5% | 20,300 | -26.7% | 0.00% | +33.3% |
Q4 2016 | $776,000 | -0.3% | 27,700 | +5.7% | 0.00% | 0.0% |
Q3 2016 | $778,000 | – | 26,200 | – | 0.00% | – |
Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2015 | $79,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |